August 05, 2016
1150 Recent Articles
August 04, 2016
Markush Group Closed to Unlisted Elements, but Open to Blends of Listed Elements
August 01, 2016
Information is Intangible, so Methods of Manipulating it are Abstract
August 01, 2016
Repeated and Consistent Usage, including in Rule 131 Declaration, Defines Term
August 01, 2016
Detailed Analysis of Specification and Prosecution History Revealed Meaning of Claims
July 28, 2016
Patent Drafters: Leaving Coining to the Mint
July 25, 2016
PTO Cannot Raise & Decide Unpatentability Theories Never Presented by the Petitioner
July 20, 2016
BioPharma Patents Quick Tips & News – July 2016
July 18, 2016
Where’s My %$^&# Dollar?
July 15, 2016
I Win? No Fair!
July 12, 2016
New After-Final Pilot Prosecution Program Allows Enhanced Patent Practice
July 11, 2016
Sale of Manufacturing Services Does Not Trigger On Sale Bar Under Pre-AIA §102
July 10, 2016
It Ain’t Over ‘Till It’s Over
July 06, 2016
And in the Alternative . . .
July 05, 2016
The Commercial Marketing Provisions of the Biologics Act are Mandatory
July 05, 2016
Not All Processes That Employ Only Independently Known Steps are Unpatentable
July 04, 2016
Plausibility vs. Enablement
July 01, 2016
Resurfacing of Preemption for Patent-Eligibility of Software Inventions – The Bascom Decision
June 28, 2016
Five IP Lessons for Small to Medium–sized Businesses
June 27, 2016